Opportunity Information: Apply for W81XWH 16 BCRP INNOV
Apply for W81XWH 16 BCRP INNOV
- The DOD-AMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Breast Cancer Innovator Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on Mar 01, 2016 and posted on Mar 01, 2016.
- Applicants must submit their applications by Aug 11, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DoD Breast Cancer Innovator Award (Funding Opportunity Number W81XWH-16-BCRP-INNOV) is a Department of Defense Breast Cancer Research Program opportunity designed to back a rare kind of applicant: an established, highly creative scientific leader whose track record shows they can challenge standard thinking and push an entire field in a new direction. Unlike many grants that are primarily project-centered, this award is explicitly people-centered. The core of the application is the Principal Investigator (PI) and the unique, paradigm-shifting contribution they are positioned to make toward ending breast cancer, supported by the resources and flexibility to pursue bold, high-risk ideas that might not fit traditional funding models.
The program is intentionally open to visionary individuals from any discipline, including those who have not previously worked in breast cancer, as long as the proposed effort is clearly focused on breast cancer. In fact, the solicitation encourages researchers from other fields to bring fresh concepts, unconventional tools, and new ways of thinking to breast cancer problems. What matters most is the PI's demonstrated ability to disrupt the status quo, introduce new frameworks or approaches (whether in research or patient care), and continue generating innovative work. Applicants are expected to articulate a compelling vision for ending breast cancer that goes beyond incremental advances and is grounded in the PI's proven capacity to lead transformative change.
The award also comes with clear expectations about commitment and leadership. The PI must dedicate 50 percent of their full-time professional effort to breast cancer research during the award period; that effort can be supported by this award alone or combined with other active funding, but the time commitment to breast cancer work must be real and sustained. The PI is also expected to be well-established and capable of building and managing strong collaborations, which is reflected in the requirement to assemble a research team with the expertise needed to carry out the overarching goals. In addition, to help cultivate the next generation of innovative thinkers, the application must include a mentoring component for promising junior investigators, making workforce development and idea generation a built-in part of the award structure.
A notable feature of this opportunity is its formal integration of patient and advocate perspectives into the research team. The PI's team must include at least two breast cancer consumer advocates who are breast cancer survivors and are actively involved in a breast cancer advocacy organization. These advocates must serve as independent lay representatives: they cannot be employees of any organization participating in the application, and their role should not be tied to their employment. They are expected to be knowledgeable about current breast cancer issues and sufficiently trained or experienced to contribute meaningfully to research discussions. Their purpose is to provide objective input that keeps the work grounded in relevance and impact for people living with breast cancer or at risk for it, strengthening the focus on outcomes that matter to the community.
Administratively, this opportunity was posted March 1, 2016, with an original and current closing date of August 11, 2016. The sponsoring agency is listed as DOD-AMRAA, and the funding instrument types include both grants and cooperative agreements under the Science and Technology/Research and Development category (CFDA 12.420). Eligibility is described as unrestricted, meaning it is broadly open to various entity types, subject to any additional eligibility clarifications in the full announcement. The notice indicates an expected single award (Expected Awards: 1), with the award ceiling not specified in the provided data. Overall, the Innovator Award is structured to empower a proven, visionary leader to pursue ambitious, unconventional breast cancer ideas with substantial independence, while also requiring meaningful mentorship and direct advocate involvement to keep innovation connected to real-world patient needs.
FAQs: DoD Breast Cancer Innovator Award (W81XWH-16-BCRP-INNOV)
What is the DoD Breast Cancer Innovator Award?
The DoD Breast Cancer Innovator Award (Funding Opportunity Number W81XWH-16-BCRP-INNOV) is a Breast Cancer Research Program opportunity that is designed to support an established, highly creative scientific leader whose work can challenge conventional thinking and push the breast cancer field in a new direction. The award is intentionally structured to enable bold, high-risk ideas that may not fit traditional funding models.
Is this award focused on the project or the person (PI)?
This opportunity is explicitly people-centered rather than primarily project-centered. The core of the application is the Principal Investigator (PI), including their track record, leadership, and their potential to deliver a paradigm-shifting contribution toward ending breast cancer.
What kind of PI is this award looking for?
The program targets an established, highly creative scientific leader with a demonstrated ability to disrupt the status quo and introduce new frameworks or approaches (in research and/or patient care). The PI is expected to present a compelling, transformative vision for ending breast cancer that goes beyond incremental advances.
Do applicants need prior experience in breast cancer research?
No. The solicitation is open to visionary individuals from any discipline, including those who have not previously worked in breast cancer, as long as the proposed effort is clearly focused on breast cancer. The program encourages researchers from other fields to bring fresh concepts, unconventional tools, and new ways of thinking to breast cancer problems.
How important is innovation and risk-taking in this opportunity?
Innovation is central. The award is intended to provide resources and flexibility for ambitious, unconventional, and potentially high-risk ideas that might not be competitive in more traditional funding structures. The PI is expected to articulate a vision that is transformative rather than incremental.
What is the required level of effort for the PI?
The PI must dedicate 50 percent of their full-time professional effort to breast cancer research during the award period. This effort can be supported entirely by this award or combined with other active funding, but the time commitment to breast cancer work must be real and sustained.
Can the PI use other funding at the same time as this award?
Yes. The required 50 percent effort devoted to breast cancer research may be supported by this award alone or combined with other active funding, as long as the PI maintains the required sustained commitment to breast cancer research during the award period.
Are collaborations and team-building expected?
Yes. The PI is expected to be well-established and capable of building and managing strong collaborations. The application must include a research team with the expertise needed to carry out the overarching goals described by the PI.
Is mentorship required as part of the application?
Yes. The application must include a mentoring component for promising junior investigators. This makes workforce development and the cultivation of future innovative thinkers a built-in part of the award structure.
Are patient or advocate perspectives required in the research team?
Yes. The opportunity formally integrates patient and advocate perspectives. The PI's team must include at least two breast cancer consumer advocates.
Who qualifies as a required breast cancer consumer advocate for this award?
The required consumer advocates must be breast cancer survivors who are actively involved in a breast cancer advocacy organization. They are expected to be knowledgeable about current breast cancer issues and sufficiently trained or experienced to contribute meaningfully to research discussions.
How many consumer advocates are required?
At least two breast cancer consumer advocates are required on the PI's team.
Do the consumer advocates have to be independent from the applicant organizations?
Yes. The consumer advocates must serve as independent lay representatives. They cannot be employees of any organization participating in the application, and their advocate role should not be tied to their employment.
What is the purpose of including consumer advocates?
Their role is to provide objective input that keeps the work grounded in relevance and impact for people living with breast cancer or at risk for it. Their involvement is intended to strengthen the focus on outcomes that matter to the breast cancer community.
What agency sponsors this funding opportunity?
The sponsoring agency is listed as DOD-AMRAA (Department of Defense).
What is the Funding Opportunity Number?
The Funding Opportunity Number is W81XWH-16-BCRP-INNOV.
When was this opportunity posted and when does it close?
The opportunity was posted on March 1, 2016. The original and current closing date listed is August 11, 2016.
What funding instrument types are available under this opportunity?
The notice lists grants and cooperative agreements as the funding instrument types.
What program area and CFDA number are associated with this opportunity?
The opportunity is in the Science and Technology/Research and Development category and is associated with CFDA 12.420.
Who is eligible to apply?
Eligibility is described as unrestricted, meaning it is broadly open to various entity types, subject to any additional eligibility clarifications that may be included in the full announcement.
How many awards are expected?
The notice indicates a single expected award (Expected Awards: 1).
Is there an award ceiling listed?
No award ceiling is specified in the provided information.
What are the key elements an application must emphasize based on this notice?
Based on the information provided, applications should emphasize the PI's demonstrated capacity for transformative, paradigm-shifting leadership; a clear and compelling vision focused on ending breast cancer; a real 50 percent effort commitment to breast cancer research; a strong team capable of executing the overarching goals; a mentoring component for junior investigators; and meaningful integration of at least two independent breast cancer survivor advocates who are active in advocacy organizations.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: Transparency and Accountability in Public Administration and Services (TAPAS)
Previous opportunity: ROSES 2016: Emerging Worlds
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 16 BCRP INNOV
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 16 BCRP INNOV) also looked into and applied for these:
| Funding Opportunity |
|---|
| ROSES 2016: Cassini Data Analysis Program Apply for NNH16ZDA001N CDAP Funding Number: NNH16ZDA001N CDAP Agency: NASA-HQ Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, Gulf Coast CESU Apply for G16AS00039 Funding Number: G16AS00039 Agency: DOI-USGS1 Category: Science and Technology and other Research and Development Funding Amount: $286,000 |
| Amyotrophic Lateral Sclerosis Research Program Therapeutic Development Award Apply for W81XWH 16 ALSRP TDA Funding Number: W81XWH 16 ALSRP TDA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2016: Topical Workshops, Symposia, and Conferences Apply for NNH16ZDA001N TWSC Funding Number: NNH16ZDA001N TWSC Agency: NASA-HQ Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2016: NASA Data for Operation and Assessment Apply for NNH16ZDA001N NDOA Funding Number: NNH16ZDA001N NDOA Agency: NASA-HQ Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Breast Cancer Breakthrough Award Levels 3 and 4 Apply for W81XWH 16 BCRP BREAKTHROUGHFL34 Funding Number: W81XWH 16 BCRP BREAKTHROUGHFL34 Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Breast Cancer Era of Hope Scholar Award Apply for W81XWH 16 BCRP EOHS Funding Number: W81XWH 16 BCRP EOHS Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Amyotrophic Lateral Sclerosis Research Program Therapeutic Idea Award Apply for W81XWH 16 ALSRP TIA Funding Number: W81XWH 16 ALSRP TIA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Breast Cancer Breakthrough Award Levels 1 and 2 Apply for W81XWH 16 BCRP BREAKTHROUGHFL12 Funding Number: W81XWH 16 BCRP BREAKTHROUGHFL12 Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Breast Cancer Distinguished Investigator Award Apply for W81XWH 16 BCRP DIA Funding Number: W81XWH 16 BCRP DIA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2016: Exoplanets Research Program Apply for NNH16ZDA001N XRP Funding Number: NNH16ZDA001N XRP Agency: NASA-HQ Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, Desert Southwest CESU Apply for G16AS00038 Funding Number: G16AS00038 Agency: DOI-USGS1 Category: Science and Technology and other Research and Development Funding Amount: $325,000 |
| Aerospace Medicine, Clinical Research, Human Performance, and Expeditionary Medicine Apply for BAA AFRL RQKHC 2016 0009 Funding Number: BAA AFRL RQKHC 2016 0009 Agency: DOD-AFRL Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2016: Rapid Response and Novel Research in Earth Science Apply for NNH16ZDA001N RRNES Funding Number: NNH16ZDA001N RRNES Agency: NASA-HQ Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2016: Ocean Surface Topography Science Team Apply for NNH16ZDA001N OSTST Funding Number: NNH16ZDA001N OSTST Agency: NASA-HQ Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY16 Supplemental to Air-Coupled Rail Inspection Prototype Using Passive Approach Apply for FR RRD 16 002 Funding Number: FR RRD 16 002 Agency: DOT-FRA Category: Science and Technology and other Research and Development Funding Amount: $286,545 |
| Research and Development for Next Generation Nuclear Physics Accelerator Facilities Apply for DE FOA 0001556 Funding Number: DE FOA 0001556 Agency: PAMS-SC Category: Science and Technology and other Research and Development Funding Amount: $1,870,000 |
| Conferences and Workshops in the Mathematical Sciences Apply for 16 550 Funding Number: 16 550 Agency: NSF Category: Science and Technology and other Research and Development Funding Amount: $100,000 |
| Plant-Biotic Interactions Apply for 16 551 Funding Number: 16 551 Agency: NSF Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Refinement of Complex Sound Technologies to Deter Apply for USFS 16 FA 0070 Funding Number: USFS 16 FA 0070 Agency: DOI-USGS1 Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 16 BCRP INNOV", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.